A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID‐19) pandemic: an international collaborative group

…, T Elfiki, G Curigliano, C Eng, A Grothey, C Xie - The …, 2020 - academic.oup.com
The main management strategies for treating cancer patients during the COVID‐19
epidemic include clear communication and education about hand hygiene, infection control …

[HTML][HTML] Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer

…, Z Huang, L Han, Y Gong, C Xie - … journal of oncology, 2021 - spandidos-publications.com
Targeted therapy with epidermal growth factor receptor (EGFR)‑tyrosine kinase inhibitors (TKIs)
is a standard modality of the 1st‑line treatments for patients with advanced EGFR‑…

[HTML][HTML] Nanoscale zeolitic imidazolate framework (ZIF)–8 in cancer theranostics: current challenges and prospects

H Xie, X Liu, Z Huang, L Xu, R Bai, F He, M Wang… - Cancers, 2022 - mdpi.com
Simple Summary The biomedical application of metal–organic frameworks in cancer theranostics
has become a research hotspot with rapid progress. As a typical representative, ZIF–8 …

SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China

J Yu, W Ouyang, MLK Chua, C Xie - JAMA oncology, 2020 - jamanetwork.com
… Author Contributions: Drs Xie and Chua had full access to all of the data in the study and take
responsibility for the integrity … Drs Chua and Xie contributed equally as co–senior authors. …

[PDF][PDF] Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

…, W Ren, J Wang, L Wu, Y Xu, Z Miao, M Sun, C Xie… - Cancer cell, 2022 - cell.com
Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal
squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial.gov: NCT03829969), …

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

…, R Wang, X Cao, X Chen, Z Lin, J Xiong, Q Lin, C Xie… - The Lancet, 2016 - thelancet.com
Background Outcomes are poor for patients with recurrent or metastatic nasopharyngeal
carcinoma and no well established first-line chemotherapy is available for the disease. We …

[HTML][HTML] Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous NSCLC: a randomized …

…, L Wang, N Yang, Y Zhang, Z Yu, Y Zhao, C Xie… - Journal of Thoracic …, 2020 - Elsevier
Introduction Sintilimab, an anti–programmed death 1 antibody, plus pemetrexed and
platinum had revealed promising efficacy for nonsquamous NSCLC in a phase 1b study. We …

Elicitin recognition confers enhanced resistance to Phytophthora infestans in potato

…, LC Keizer, JI Zhou, TWH Liebrand, C Xie… - Nature plants, 2015 - nature.com
Potato late blight, caused by the destructive Irish famine pathogen Phytophthora infestans,
is a major threat to global food security 1, 2. All late blight resistance genes identified to date …

[HTML][HTML] USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

…, C He, Y Sun, H Li, J Shi, X Xiao, B Xiang, C Xie… - Nature …, 2022 - nature.com
Anti-PD-1/PD-L1 immunotherapy has achieved impressive therapeutic outcomes in patients
with multiple cancer types. However, the underlined molecular mechanism(s) for moderate …

[HTML][HTML] Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID‐19

…, H Zhang, J Peng, J Hu, M Chen, Y Zhong, C Xie - Psycho …, 2020 - ncbi.nlm.nih.gov
1. BACKGROUND The outbreak of 2019 novel coronavirus disease (COVID‐19) caused not
only extraordinary public health concerns but also tremendous psychological distress. 1 …